Mike Diem is a Principal at SR One and a member of the Metastatix Board of Directors.
He joined SR One in 2005 and is a Kauffman Fellow. He is currently a board director at CalciMedica and a board observer at Trinity Biosystems and Protez Pharmaceuticals.

(more…)

Johns Hopkins University offers an MBA program in Medical Services Management.

(more…)

George Washington University’s mission is to serve current and future leaders in the global community by offering superior learning opportunities in business and management. The university engages in research and other scholarly activities to advance management theory and practice, and provides management and professional expertise to business, government and not-for-profit organizations. (more…)

Dr. Whitcomb joined Frazier Healthcare Ventures in mid-2007 as a Senior Advisor to the Biopharma investment team. Prior to Frazier Healthcare, Dr. Whitcomb was a Founder and Senior Clinical Research Fellow at QuatRx Pharmaceuticals and currently serves as a consultant to multiple biotechnology companies. (more…)

Over half of the doctors age 50-65 are planning to retire, seek non-clinical jobs, or significantly reduce the number of patients they see during the next 3 years, according to a survey conducted by Merritt, Hawkins, and Associates. (more…)

Dr. Northrup is a visionary pioneer in the field of women’s health and wellness. A board-certified OB/GYN physician who graduated from Dartmouth Medical School and did her residency at Tufts New England Medical Center, Dr. Northrup was also an assistant clinical professor of ob/gyn at Maine Medical Center for over 20 years. (more…)

Dr. Peter Edelstein joined Aragon Surgical, Inc. as President and Chief Executive Officer and as a member of the Board of Directors in August 2005, just prior to the company’s Series A1 financing. Previously, Dr. Edelstein had participated in the development and analysis of the company’s initial market research and in the pre-clinical evaluation of Aragon Surgical’s electrosurgical technology. (more…)

Vice-Chair and Professor of Surgery at Columbia University, Mehmet Oz, MD, MBA, directs the Cardiovascular Institute and Complementary Medicine Program at New York Presbyterian Hospital. (more…)

The line between medical devices, pharmaceuticals, and biologics is becoming a blur with evolving technology and the combination of pharmaceutical components with medical devices.  The “combination products market” is estimated at $5.9B in 2004, and it is expected to grow upwards of 14% per year through 2010. Combination products often present complex challenges in design, regulatory approval, testing, manufacturing, labeling, and packaging.  This timely event will focus on this growing trend of convergence in the healthcare sector, providing professionals with a unique opportunity for cross-sector collaborations. (more…)

An executive search firm is currently looking to fill the following position: Medical Director, in Illinois. The Medical Director for Cardio/Radiology & Nuclear Medicine plays a key role in the creation and implementation of drug development strategies and will work closely with the Clinical and Drug Development Project Teams in order to facilitate this process. (more…)